Assessment of the Diagnostic Validities of Serum NGAL, KIM-1, and L-FABP in Patients With Chronic Kidney Disease
Open Access
- 30 June 2020
- journal article
- Published by Maad Rayan Publishing Company in International Journal of Basic Science in Medicine
- Vol. 5 (2), 48-53
- https://doi.org/10.34172/ijbsm.2020.10
Abstract
Introduction: Chronic kidney disease (CKD) is one of the most threatening and important disorders worldwide in both industrial and developing nations. In addition, neutrophil gelatinase-associated lipocalin (NGAL), liver-type fatty acid-binding protein (L-FABP), and kidney injury molecule-1 (KIM-1) are three factors suggested as diagnostic and prognostic biomarkers in CKDs. Considering the lack of enough efficiency of the creatinine in the prognosis of the CKD, the present study aimed to assess the relationship between these three factors and CKD occurrence and determine if they could be considered valid biomarkers in this regard. Materials and Methods: The present case-control study was designed enrolling 42 patients with confirmed CKD referring to the Imam Khomeini hospital of Kangan. The participants were 42 years old and gender-matched healthy counterparts. Blood samples were obtained, and then NGAL, KIM-1, and L-FABP were determined by the enzyme-linked immunosorbent assay using commercial kits (Bioassay Technology Laboratory). Finally, the serum creatinine was detected by applying Jaffe’s method. Results: Based on the results, significant differences were found in the serum levels of all four factors between CKD patients and the control group. More precisely, the serum levels of NGAL (P < 0.0001, specificity: 87.6%, sensitivity: 79.3%, and the area under the curve, AUC: 0.89), L-FABP (P < 0.0001, specificity: 83.3%, sensitivity: 78.3%, and AUC: 0.86), KIM-1 (P < 0.0001, specificity: 85.7%, sensitivity: 78.6%, and AUC: 0.88), and creatinine (P < 0.0001) were significantly higher in individuals with CKDs in comparison with controls. Eventually, the serum levels of NGAL, L-FABP, and KIM-1 were significantly correlated with each other in both patient and control groups (P < 0.0001). Conclusion: In general, NGAL, L-FABP, KIM-1, and creatinine could be used as independent biomarkers for the diagnosis of CKD. Moreover, the measurement of NGAL, L-FABP, and KIM-1 altogether could be a valid assessment for the diagnosis of CKD.Keywords
This publication has 24 references indexed in Scilit:
- Sepsis and AKI in ICU Patients: The Role of Plasma BiomarkersCritical Care Research and Practice, 2012
- Baclofen-induced encephalopathy in patient with end stage renal disease: Two case reportsIndian Journal of Nephrology, 2012
- Lipocalin 2 is essential for chronic kidney disease progression in mice and humansJCI Insight, 2010
- Early Biomarkers of Renal InjuryCongestive Heart Failure, 2010
- Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in renal allograft recipientsClinical Transplantation, 2009
- Urinary L-Type Fatty Acid-Binding Protein Can Reflect Renal Tubulointerstitial InjuryThe American Journal of Pathology, 2009
- Public Health Surveillance of CKD: Principles, Steps, and ChallengesAmerican Journal of Kidney Diseases, 2009
- Effect of Renin-Angiotensin-Aldosterone System Inhibition, Dietary Sodium Restriction, and/or Diuretics on Urinary Kidney Injury Molecule 1 Excretion in Nondiabetic Proteinuric Kidney Disease: A Post Hoc Analysis of a Randomized Controlled TrialAmerican Journal of Kidney Diseases, 2009
- Emerging urinary biomarkers in the diagnosis of acute kidney injuryExpert Opinion on Medical Diagnostics, 2008
- NGAL is an early predictive biomarker of contrast-induced nephropathy in childrenPediatric Nephrology, 2007